1101 related articles for article (PubMed ID: 19631446)
1. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
Goldstein AT; Thaçi D; Luger T
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):22-9. PubMed ID: 19631446
[TBL] [Abstract][Full Text] [Related]
2. Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood.
Boms S; Gambichler T; Freitag M; Altmeyer P; Kreuter A
BMC Dermatol; 2004 Oct; 4(1):14. PubMed ID: 15485581
[TBL] [Abstract][Full Text] [Related]
3. The role of topical calcineurin inhibitors in atopic dermatitis.
Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
[TBL] [Abstract][Full Text] [Related]
4. Potential new indications of topical calcineurin inhibitors.
Luger T; Paul C
Dermatology; 2007; 215 Suppl 1():45-54. PubMed ID: 18174692
[TBL] [Abstract][Full Text] [Related]
5. Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series.
Lonsdale-Eccles AA; Velangi S
Br J Dermatol; 2005 Aug; 153(2):390-4. PubMed ID: 16086755
[TBL] [Abstract][Full Text] [Related]
6. Pimecrolimus for the treatment of vulvar lichen sclerosus: a report of 4 cases.
Goldstein AT; Marinoff SC; Christopher K
J Reprod Med; 2004 Oct; 49(10):778-80. PubMed ID: 15568399
[TBL] [Abstract][Full Text] [Related]
7. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
Hebert AA
Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
[TBL] [Abstract][Full Text] [Related]
8. Topical use of pimecrolimus in atopic dermatitis: update on the safety and efficacy.
Werfel T
J Dtsch Dermatol Ges; 2009 Sep; 7(9):739-42. PubMed ID: 19650820
[TBL] [Abstract][Full Text] [Related]
9. [Topical treatment of vulvar lichen sclerosus with calcineurin inhibitors].
Maassen MS; van Doorn HC
Ned Tijdschr Geneeskd; 2012; 156(36):A3908. PubMed ID: 22951124
[TBL] [Abstract][Full Text] [Related]
10. Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal girl.
Goldstein AT; Marinoff SC; Christopher K
J Pediatr Adolesc Gynecol; 2004 Feb; 17(1):35-7. PubMed ID: 15010037
[TBL] [Abstract][Full Text] [Related]
11. Topical pimecrolimus for skin disease other than atopic dermatitis.
Wollina U; Hansel G; Koch A; Abdel-Naser MB
Expert Opin Pharmacother; 2006 Oct; 7(14):1967-75. PubMed ID: 17020422
[TBL] [Abstract][Full Text] [Related]
12. Role of topical calcineurin inhibitors in the treatment of seborrheic dermatitis: a review of pathophysiology, safety, and efficacy.
Cook BA; Warshaw EM
Am J Clin Dermatol; 2009; 10(2):103-18. PubMed ID: 19222250
[TBL] [Abstract][Full Text] [Related]
13. Association between exposure to topical tacrolimus or pimecrolimus and cancers.
Hui RL; Lide W; Chan J; Schottinger J; Yoshinaga M; Millares M
Ann Pharmacother; 2009 Dec; 43(12):1956-63. PubMed ID: 19903860
[TBL] [Abstract][Full Text] [Related]
14. Innovative use of topical calcineurin inhibitors.
Lin AN
Dermatol Clin; 2010 Jul; 28(3):535-45. PubMed ID: 20510763
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of topical pimecrolimus in the treatment of chronic vulvar pruritus: a prospective case series--a non-controlled, open-label study.
Sarifakioglu E; Gumus II
J Dermatolog Treat; 2006; 17(5):276-8. PubMed ID: 17092857
[TBL] [Abstract][Full Text] [Related]
16. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.
Ingram JR; Martin JA; Finlay AY
Am J Clin Dermatol; 2009; 10(4):229-37. PubMed ID: 19489656
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of anogenital lichen sclerosus with topical tacrolimus.
Böhm M; Frieling U; Luger TA; Bonsmann G
Arch Dermatol; 2003 Jul; 139(7):922-4. PubMed ID: 12873890
[TBL] [Abstract][Full Text] [Related]
18. Pimecrolimus in dermatology: atopic dermatitis and beyond.
Gisondi P; Ellis CN; Girolomoni G
Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622
[TBL] [Abstract][Full Text] [Related]
19. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
Hultsch T; Kapp A; Spergel J
Dermatology; 2005; 211(2):174-87. PubMed ID: 16088174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
